Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “RA”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01078116
What this trial is testing

Cost Utility Analyses of Adalimumab Treatment in Patients With Rheumatoid Arthritis (RA)

Who this might be right for
Rheumatoid Arthritis
Abbott 124
Testing effectiveness (Phase 2)Looking for participantsNCT06599658
What this trial is testing

COVID-19 Booster and IIV Schedule in Immunocompromised Hosts

Who this might be right for
COVID 19InfluenzaRheumatoid Arthritis (RA)+5 more
McGill University Health Centre/Research Institute of the McGill University Health Centre 660
Early research (Phase 1)Looking for participantsNCT06994143
What this trial is testing

CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis (RA
Cullinan Therapeutics Inc. 37
Not applicableLooking for participantsNCT06889415
What this trial is testing

Rheumatoid Arthritis and Osteosarcopenia: Associated Factors

Who this might be right for
OsteosarcopeniaRheumatoid Arthritis (RA)Sarcopenia
Konya Beyhekim Training and Research Hospital 200
Early research (Phase 1)Study completedNCT06055023
What this trial is testing

Phase I Clinical Study of ZL-82 Tablets

Who this might be right for
Rheumatoid Arthritis (RA)Inflammatory Bowel Disease - IBD1
Chengdu Zenitar Biomedical Technology Co., Ltd 69
Not applicableUnknownNCT02887625
What this trial is testing

Exenatide Plus Pioglitazone Versus Insulin in Poorly Controlled T2DM

Who this might be right for
Type 2 Diabetes
Dr. Muhammad Abdulghani 410
Post-approval studies (Phase 4)WithdrawnNCT01067430
What this trial is testing

Comparison of the Effect of Etoricoxib and Diclofenac on Early Morning Activity in Rheumatoid Arthritis (RA)

Who this might be right for
Rheumatoid Arthritis
Northumbria Healthcare NHS Foundation Trust
Not applicableEnded earlyNCT01083563
What this trial is testing

Draining PLN and Synovial Inflammation in RA Knee Joints Pre and Post Anti-TNF or B Cell Depletion Therapy

Who this might be right for
Rheumatoid Arthritis
University of Rochester 7
Testing effectiveness (Phase 2)WithdrawnNCT01204138
What this trial is testing

Concomitant Use of Apremilast for the Treatment of Active RA Despite TNF-Inhibition and Methotrexate- CATARA

Who this might be right for
Arthritis, Rheumatoid
Stanford University
Testing effectiveness (Phase 2)WithdrawnNCT00845104
What this trial is testing

Fludarabine Phosphate, Rituximab, and Bevacizumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia That Has Relapsed or Not Responded To Treatment

Who this might be right for
B-cell Chronic Lymphocytic LeukemiaRefractory Chronic Lymphocytic Leukemia
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Not applicableLooking for participantsNCT06256419
What this trial is testing

Association of Gene Polymorphism With Susceptibility to T2DM and the Therapeutic Responses to Exenatide in Chinese Patients With T2DM

Who this might be right for
Type 2 Diabetes MellitusSusceptibility, Genetic
The Affiliated Hospital of Xuzhou Medical University 300
Large-scale testing (Phase 3)Study completedNCT00535782
What this trial is testing

The Effect of Tocilizumab on Markers of Atherogenic Risk in Patients With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 132
Early research (Phase 1)Ended earlyNCT00458159
What this trial is testing

A Phase I, Open-Label, Dose-Escalation Study of CC-11006 In Subjects With Low- or Intermediate-1 Risk Myelodysplastic Syndromes

Who this might be right for
Myelodysplastic Syndrome
Celgene 34
Post-approval studies (Phase 4)UnknownNCT03895879
What this trial is testing

Use of Tocilizumab Drug Levels to Optimize Treatment in RA

Who this might be right for
Rheumatoid Arthritis
Reade Rheumatology Research Institute 98
Not applicableNot Yet RecruitingNCT06783322
What this trial is testing

Long-term Outcomes of Patients with Rheumatoid Arthritis in Remission

Who this might be right for
Rheumatoid Arthritis (RA)
Diakonhjemmet Hospital 259
Early research (Phase 1)Looking for participantsNCT07171983
What this trial is testing

Evaluate the Safety, Tolerability, and Drug Levels of BMS-986454 in Participants With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Bristol-Myers Squibb 46
Testing effectiveness (Phase 2)Study completedNCT01701596
What this trial is testing

Safety and Efficacy of Rotational Atherectomy (RA) in Coronary Dissection

Who this might be right for
Coronary Artery Disease
Xijing Hospital 198
Not applicableStudy completedNCT07287696
What this trial is testing

Effect of Siwan Sand Therapy on Pulmonary Functions of Rheumatoid Arthritis Patients

Who this might be right for
Rheumatoid Arthritis (RA
Ahram Canadian University 15
Large-scale testing (Phase 3)Study completedNCT01347983
What this trial is testing

Extension Study of Tocilizumab Long Term Treatment of Moderate to Severe Rheumatoid Arthritis Patients

Who this might be right for
Rheumatoid Arthritis
Chugai Pharma Taiwan 72
Testing effectiveness (Phase 2)Study completedNCT00462150
What this trial is testing

Effects of Home-Based Emotional Disclosure in Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
UMC Utrecht 80
Next Page